Lung Cancer Trials Ask AI to find trials
CompletedNot applicableNCT06028152
Official study title

Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning

Study summary

The goal of this clinical trial is to explore feasibility, acceptability, and effectiveness of end-of-life conversation game "Hello" as a tool to help individuals with breast, lung, and/or genito-urinary cancers treated at Penn State Cancer Institute and their loved ones perform advance care planning. The main questions it aims to answer are: * What modifications and/or adaptations are necessary to Hello for use in cancer populations? * How do different delivery models compare for recruitment in terms of feasibility and efficiency? Participants will: * Complete pre-game questionnaires * Play the Hello game * Complete post-game questionnaires * Participate in a focus group

Ask AI to explain this study
Start here

Key things to know

Main goalSupportive Care

This describes the study’s primary purpose.

What is being studiedEnd-of-life conversation game called "Hello"

The study team can explain what participation involves.

Who it may be forBreast Cancer · Lung Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Feb 28, 2024 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Milton S. Hershey Medical Center

Study sponsor

01
Study overview

What this study is about

Purpose
Supportive Care
Study type
Interventional
Phase
Not applicable
Sponsor
Milton S. Hershey Medical Center
Interventions being studied
Other: End-of-life conversation game called "Hello"
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • Cancer Patient:
  • Adults (\> 18 years old)
  • Able to speak and read English
  • Be an individual diagnosed with breast, lung, or genitourinary/prostate cancer as verified by primary oncologist or is the chosen caregiver for a participant with those cancers
  • Receives care at Penn State Health or is the chosen caregiver for a participant treated at Penn State Health Inclusion Criteria Caregiver/Loved one:
  • Adults (\> 18 years old)
  • Able to speak and read English and/or Spanish
  • Be the chosen caregiver for a participant with cancer
Reasons someone may not be able to joinExclusion criteria
  • Cancer Patient:
  • Anyone \<18 years of age
  • Anyone unable to speak and read English
  • Unable to provide informed consent
  • Receives cancer care exclusively outside of Penn State Health

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Penn State Cancer InstituteHershey, Pennsylvania

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Feb 28, 2024. Always confirm current availability with the study team.

View original record ↗